Thanks Julie. In the first quarter of the class our shares of the research opportunity fund returned 12.96% versus 11.07% for Russell 3000. Since inception four years ago, research opportunities have generated strong absolute returns with an average net exposure of 69%. But during this strong period for equities the fund has modestly trail along on the benchmark. Over four market cycle however we expect to have value relevant to our path of long only benchmark. Now turning to the next page, number of long names into the portfolio decreased 62 from 65 a quarter ago. Number of short names increased to 20 from 12. Consequently our net exposure declined to 67% from 78%. In terms of sector allocation, the financial sector continues to represent our largest long exposure, consumer discretionary represents our largest short exposure. No significant change, sector weights in the quarter was within the industrial sector, declining on the long side for roughly 400 basis points from 14.5% to 10.5% due to the elimination of the airline holdings. Turning to next page, our top 10 holdings are fairly consistent in the last quarter and with change being Assured Guaranty was replaced by IStar Financial, this was caused by turning the Assured position based upon it having appreciated towards estimate of intrinsic value. During the quarter we had 8 new names, AIG, Dollar General, discount retailer, United Health, the health insurer which has been owned elsewhere (inaudible) and five of the names have already been mentioned, the new ones were Aaron’s, Orthofix, First American, Principal Financial and Warner Chilcott. In terms of eliminations during the quarter we eliminated 8 names, Alaska Air, Leisure Travel, Hi-Tech HiTech Pharma, HollyFrontier, Imax, Medtronic, Redwood Trust and Excel Group. The hope of Medtronic remains appreciated considerably toward our estimate of intrinsic value. Medtronic was eliminated to freed up capital for other opportunities in the healthcare team. Turning to next page, focus on one top performer and one poor performer, I think the long top performers have already each been addressed, so I will talk about Occupy which is one of my -- short holding stock sold off after earnings and after analyst day, meeting its (inaudible) largely to some kind of pressure due to increased operating expenses for (inaudible). In terms of the bottom performer I mention financial services, assist corporations and government entities in the disposal and monetization of surplus scrap inventory. The company reported in line earnings but 13 times was below expectations, as well as below previously issued guidance. Despite this near term softness the analysts companies name, at least the company is strong with opportunities and the stock is undervalued relative to its intrinsic value. With that, I will hand back over to you.